Overview

A Study to Examine the Effect of Particle Size on Bioequivalence and Bioavailability

Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to measure the amount of study drug that is in your blood after you receive a different type of tablet in each of four study visits.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline